What is the appropriate management for severe hand eczema in a 10‑year‑old child?

Management of Severe Hand Eczema in a 10-Year-Old

For severe hand eczema in a 10-year-old child, initiate intensive topical therapy with medium-to-high potency topical corticosteroids (Class II-III) applied once to twice daily for 1-4 weeks, combined with liberal emollient use, while simultaneously investigating for contact allergens through patch testing and treating any secondary bacterial infection.

Initial Diagnostic Approach

Before escalating treatment, you must distinguish between atopic, irritant, and allergic contact dermatitis, as clinical features alone are unreliable in distinguishing these etiologies in children with hand eczema 1. Take a focused history addressing:

• Personal and family history of atopic dermatitis, asthma, or hay fever
• Initial symptom location and spread pattern
• Relationship to specific products (soaps, hand sanitizers, cosmetics, gloves)
• Detailed history of all wash products and frequency of hand washing
• Activities triggering symptoms (sports, hobbies, school activities)
• Improvement during school breaks or weekends
• Presence of secondary infection signs (oozing, crusting, pustules)

Consider patch testing even in children with known atopic dermatitis, as the two conditions frequently coexist and clinical morphology cannot reliably distinguish them 1.

First-Line Treatment Protocol

Intensive Topical Therapy

Start with a clearance phase using medium-to-high potency topical corticosteroids (Class II-III in US classification) applied once to twice daily for 1-4 weeks 2. In a 10-year-old, avoid the strongest Class I steroids but don't undertreate with weak preparations. Apply to affected areas after hand washing and drying.

After achieving control, transition to proactive maintenance therapy with the same corticosteroid applied 2-3 times weekly to previously affected areas to prevent flares 2.

Emollient Therapy

Prescribe adequate quantities of emollients for liberal, frequent application—this is non-negotiable 3. Children require approximately 250-500g weekly for hand eczema. Apply immediately after washing hands and throughout the day. Ointment-based formulations provide superior barrier repair compared to creams.

Infection Management

If secondary bacterial infection is suspected (honey-colored crusting, weeping, rapid worsening), obtain bacterial swabs and initiate flucloxacillin as first-line antibiotic therapy for Staphylococcus aureus 3. Use erythromycin if penicillin-allergic. Treat for 7-10 days.

If viral infection (eczema herpeticum) is suspected—grouped vesicles, punched-out erosions, fever—initiate oral acyclovir immediately and consider hospitalization for IV therapy if systemically unwell 3.

Adjunctive Measures

Trigger Avoidance and Protection

• Identify and eliminate irritants: excessive hand washing, harsh soaps, alcohol-based sanitizers
• Use cotton-lined vinyl or nitrile gloves for wet work (avoid latex)
• Apply emollients before and after potential exposures
• Avoid direct contact with potential allergens identified through history

Antihistamines

Sedating antihistamines (e.g., hydroxyzine, diphenhydramine) may be used short-term at bedtime for severe pruritus interfering with sleep 3. Non-sedating antihistamines have minimal value in eczema. Large doses may be required in children, but avoid daytime use to prevent school performance impairment.

When to Escalate Beyond First-Line Therapy

Refer to dermatology if the child fails to respond after 4 weeks of optimized intensive topical therapy with documented adherence 2. Failure to respond warrants:

1. Patch testing with baseline and extended allergen series to identify contact allergens 1
2. Consideration of second-line therapies including:
   • Topical calcineurin inhibitors (tacrolimus 0.03% or 0.1%) for steroid-sparing maintenance 1
   • Phototherapy (narrowband UVB) if child can cooperate with treatment 1, 4
   • Wet wrap therapy for acute severe flares 2

Critical Pitfalls to Avoid

Do not prescribe systemic corticosteroids for maintenance therapy in children—the risks of growth suppression and pituitary-adrenal axis suppression outweigh benefits 3. They have only a limited role for severe acute flares under specialist supervision.

Do not assume atopic hand eczema excludes contact allergy—up to two-thirds of hand eczema cases have multifactorial etiology 1, 5. The pattern and morphology are unreliable predictors.

Do not underprescribe emollients—inadequate quantities lead to poor adherence and treatment failure. Write specific quantities (e.g., "500g emollient ointment, apply liberally to hands 6-8 times daily").

Do not delay patch testing in chronic cases—waiting months while trying multiple topical therapies wastes time if an avoidable allergen is the culprit 1.

Monitoring and Follow-Up

Reassess at 2-4 weeks to evaluate:

• Treatment adherence (ask patient to bring all products to appointment)
• Clinical response using objective measures (Hand Eczema Severity Index)
• Presence of complications (infection, steroid atrophy)
• Impact on quality of life and school functioning

If inadequate response despite documented adherence, this constitutes treatment failure requiring specialist referral and consideration of systemic therapies, though options in children are limited and typically reserved for severe refractory cases under specialist care 2, 6.